These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 30624737
21. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ. Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117 [Abstract] [Full Text] [Related]
22. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G, McKevitt M, Elborn JS, Tunney MM. J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067 [Abstract] [Full Text] [Related]
23. Effect of pH on the antimicrobial susceptibility of planktonic and biofilm-grown clinical Pseudomonas aeruginosa isolates. Moriarty TF, Elborn JS, Tunney MM. Br J Biomed Sci; 2007 May; 64(3):101-4. PubMed ID: 17910277 [Abstract] [Full Text] [Related]
24. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro. Bahamondez-Canas TF, Zhang H, Tewes F, Leal J, Smyth HDC. Mol Pharm; 2018 Apr 02; 15(4):1643-1652. PubMed ID: 29514003 [Abstract] [Full Text] [Related]
26. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms. Beaudoin T, Stone TA, Glibowicka M, Adams C, Yau Y, Ahmadi S, Bear CE, Grasemann H, Waters V, Deber CM. Sci Rep; 2018 Oct 03; 8(1):14728. PubMed ID: 30283025 [Abstract] [Full Text] [Related]
31. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo X, Yu HY, Ariza J, Li J. J Antimicrob Chemother; 2014 Sep 03; 69(9):2434-42. PubMed ID: 24833752 [Abstract] [Full Text] [Related]
32. Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance. Maiden MM, Waters CM. PLoS Pathog; 2020 Oct 03; 16(10):e1008529. PubMed ID: 33125434 [Abstract] [Full Text] [Related]
33. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms. Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM. Antimicrob Agents Chemother; 2017 Nov 03; 61(11):. PubMed ID: 28848007 [Abstract] [Full Text] [Related]
35. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections. Rojo-Molinero E, Macià MD, Rubio R, Moyà B, Cabot G, López-Causapé C, Pérez JL, Cantón R, Oliver A. Antimicrob Agents Chemother; 2016 May 03; 60(5):2912-22. PubMed ID: 26926631 [Abstract] [Full Text] [Related]
36. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin. Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA. Antimicrob Agents Chemother; 2007 May 03; 51(5):1813-7. PubMed ID: 17353241 [Abstract] [Full Text] [Related]
37. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Anderson GG, Moreau-Marquis S, Stanton BA, O'Toole GA. Infect Immun; 2008 Apr 03; 76(4):1423-33. PubMed ID: 18212077 [Abstract] [Full Text] [Related]
38. Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro. Bandara HM, Harb A, Kolacny D, Martins P, Smyth HD. AAPS PharmSciTech; 2014 Dec 03; 15(6):1644-54. PubMed ID: 25155975 [Abstract] [Full Text] [Related]
39. Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity. Agyeman AA, López-Causapé C, Rogers KE, Lucas DD, Cortés-Lara S, Gomis-Font MA, Fraile-Ribot P, Figuerola J, Lang Y, Franklyn ERT, Lee WL, Zhou J, Zhang Y, Bulitta JB, Boyce JD, Nation RL, Oliver A, Landersdorfer CB. Int J Antimicrob Agents; 2023 Sep 03; 62(3):106887. PubMed ID: 37315906 [Abstract] [Full Text] [Related]
40. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE, Naimie AA, Griffin EF, Bay C, O'Toole GA. J Bacteriol; 2016 Jan 15; 198(2):237-47. PubMed ID: 26483523 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]